fbpx

Simon J. Hickling, Ph.D.

Willow Biosciences, Inc.
SVP - Business Development
Company:
Willow Biosciences, Inc
Title:
Business Development

Speeches by Simon J. Hickling

[22nd April ]
TBC
Theme: The seminar will introduce the audience to the biosynthetic production of cannabinoids, through fermentation in brewer’s yeast. The resultant products are pure, consistent and sustainable, and rare cannabinoids - present in trace amounts in the plant - can be readily produced at scale. Willow’s FutureGrown cannabigerol (CBG) will be introduced, demonstrating its potential as a “hero” active ingredient in skincare products.

Personal Information

Dr. Hickling has 25 years’ experience of production and business development in the pharmaceutical and biotech industries, having previously held roles at DSM, Codexis and PharmaZell. His focus has been on cutting-edge technologies in highly regulated markets. He received his B.Sc. (Hons) from Sheffield Hallam University, and Ph.D. from the University of Bath.

Business Solutions
100%
International Trends
100%
Manufacturing
100%

Contact Me